GSK plc (LSE:GSK) is looking for M&A. Emma Walmsley, CEO said, "Well, I think we've been extremely clear and consistent in our priorities for BD because it's -- it might be M&A. Sometimes it's different kinds of business development and partnering as well. But what was weird was GSK not doing it. We now do about -- I think, about 50% of our portfolio is like the partner or bought in, which is much closer to normal.

And it is a priority. And Julie laid out very clearly our capital allocation priorities to be investing in growth, both organically and inorganically as well as returns to shareholders, all underpinned by a strong balance sheet. And that's really the work we've been focused on".